Sai Life Sciences IPO subscription status started on Wednesday, December 11, 2024, and will close on December 13, 2024. The IPO aims to raise approximately ₹3,042.62 crores through public issuance. The allocation for investor categories includes 35% for Retail Investors, 50% for Qualified Institutional Buyers (QIBs), and 15% for Non-Institutional Investors (NII). The price band is set at ₹522 to ₹549 per equity share, offering an opportunity for investors to participate in this anticipated offering.
The Sai Life Sciences IPO requires a minimum market lot of 27 shares, amounting to an application value of ₹14,823. This IPO is classified as a Mainboard IPO and will be listed on the BSE & NSE.
About Sai Life Sciences
Founded in January 1999, Sai Life Science Limited is a leading Contract Research, Development, and Manufacturing Organization (CRDMO) that partners with innovative pharmaceutical and biotech companies to advance drug discovery, development, and manufacturing of small-molecule new chemical entities (NCEs). Leveraging its deep scientific expertise, the company addresses critical healthcare challenges and aspires to develop groundbreaking medicines for currently incurable conditions, shaping the future of healthcare. Sai Life Sciences customizes its services to meet the unique needs of diverse clients, ranging from small enterprises to global pharmaceutical giants, showcasing adaptability and resilience.
With strong growth in the CRDMO sector, the company has achieved significant revenue and EBITDA CAGRs from FY 2022 to FY 2024, outpacing competitors. Over its 24-year journey, it has successfully delivered a wide range of NCE development programs for clients, emphasizing quality, affordability, and responsiveness. These three pillars remain the foundation of Sai Life Science’s exceptional value to its partners.
GMP on IPO of Sai Life Sciences
For the latest updates on Sai Life Sciences IPO Grey Market Premium (GMP) and GMP of IPOs, please visit our IPO GMP Page. Stay informed on premium trends and investor interest before making your investment decision.
BapuKhabar View on Sai Life Sciences
We recommend investors consider applying for this IPO with a Long-Term Perspective, as it holds potential for growth in the coming years. However, before committing, it’s wise to review the QIB, NII, and Retail subscription numbers.
Sai Life Sciences IPO Subscription Status (Day Wise)
| Category | Day 1 | Day 2 | Day 3 |
|---|---|---|---|
| QIB | 2.52 | 3.20 | 29.78 |
| NII | 0.16 | 0.60 | 4.99 |
| RII | 0.19 | 0.43 | 1.39 |
| Total | 0.85 | 1.26 | 10.27 |
Investor Insights
Employee Category (EMP): Reserved specifically for eligible employees, providing an opportunity to invest at the IPO price.
Qualified Institutional Buyers (QIB): Typically larger institutions, including mutual funds and banks, this category has shown [interest level, e.g., strong demand].
Non-Institutional Investors (NII): Includes corporate bodies and HNIs who often bid for a significant portion.
Retail Individual Investors (RII): Subscription levels in this category reflect the enthusiasm of individual retail investors.
Sai Life Sciences IPO Review and Rating
- Recommendation: Apply
- Rating: ★☆☆☆☆ (1/5)
Sai Life Sciences IPO Forms
How to apply for the Sai Life Sciences IPO?
You can apply for the Sai Life Sciences IPO through the ASBA option available in your bank account. Simply log in to your online banking, navigate to the Invest section, and select the Sai Life Sciences IPO to apply directly. Alternatively, you can apply using IPO forms downloaded online. Download the blank Sai Life Sciences IPO forms, fill them out, and submit them at your bank or through your broker.
FAQs
When will the Sai Life Sciences IPO Subscription Start?
The IPO subscription starts on December 11, 2024 for QIB, NII, and Retail Investors.
How to Subscribe to the IPO?
You can subscribe via ASBA or non-ASBA options. Log in to your bank account and apply for the IPO through ASBA, or download the IPO application form, fill it out, and submit it to your broker or bank.
How Can I Check Live Sai Life Sciences IPO Subscription Numbers Today?
Visit our portal for live IPO subscription updates, which we refresh hourly from official sources. You can also check live subscription data on the official websites associated with the IPO.
How to Apply for the IPO through Zerodha?
- Log in to your Zerodha account (website or app).
- Go to Portfolio and select IPO.
- Select the IPO name and click on the Bid button.
- Enter your UPI ID, quantity, and price, then submit the application.
- Approve the mandate in your UPI app or Net Banking/BHIM App.
How to Apply for the IPO through Upstox?
- Log in to your Upstox account.
- Select the IPO name and click on Bid.
- Confirm your application and go to your UPI app or Net Banking/BHIM App to approve the mandate.
How to Apply for the IPO through Paytm Money?
- Log in to Paytm Money and select the IPO name.
- Click on the Bid button and confirm your application.
- Approve the mandate through your UPI app or Net Banking/BHIM App.
Stay updated with the latest IPO news on Bapukhabar. Explore key pages like IPO GMP for the latest (Grey Market Premium) GMP on IPO, IPO Listing for recent and upcoming listings on NSE & BSE, IPO Subscription for real-time subscription data, IPO Allotment to check your allotment status, IPO Forms for application details, and SME IPO for updates on Small and Medium Enterprise IPOs.
Follow us on Instagram, Facebook, and Twitter for instant updates and more!
